Eddit
32371564 2020. Clinical presentation and course of COVID-19
32366502 2020. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies
32252141 2020. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)
32252139 2020. Epidemiology and clinical features of coronavirus disease 2019 in children
32207680 2020. COVID-19: the new challenge for rheumatologists
32197957 ä. What Should Gastroenterologists and Patients Know About COVID-19?
32276137 ä. Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
32325252 2020. COVID-19 pathophysiology: A review
32311462 2020. On the molecular determinants of the SARS-CoV-2 attack
32129843 ä. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients
32129842 ä. A glimpse into the origins of genetic diversity in SARS-CoV-2
32220422 2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections
32271376 ä. Factors associated with prolonged viral RNA shedding in patients with COVID-19
32339487 2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China
32333860 2020. Presepsin in risk stratification of SARS-CoV-2 patients
32161940 ä. Dysregulation of immune response in patients with COVID-19 in Wuhan, China
32145275 2020. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
32348783 2020. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
32202240 2020. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
32358954 ä. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing
32361747 ä. COVID-19, superinfections and antimicrobial development: What can we expect?
32173725 ä. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China
32161968 ä. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias
32271373 ä. Predictors of refractory Coronavirus disease (COVID-19) pneumonia
32250159 2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients
32178975 ä. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
32371557 2020. SARS-CoV-2 and myocardial injury: Few answers, many questions
32357210 ä. Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19)
32215618 ä. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study
32371556 2020. Hyperglycemia management in the critically ill patient with COVID-19
32205220 ä. Don t Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19)
32278065 ä. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management
32334083 ä. Current Knowledge and Research Priorities in the Digestive Manifestations of COVID-19
32311512 ä. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19
32283325 ä. Clinical Features of COVID-19-Related Liver Damage
32334082 ä. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
32270184 ä. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19
32215622 ä. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility
32360478 2020. Emerging key laboratory tests for patients with COVID-19
32077933 ä. ...Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak
32154877 ä. The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception
32246822 ä. Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads
32353116 ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything
32343775 ä. SARS-CoV-2 Serology: Much Hype, Little Data
32315390 ä. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform
32282874 ä. Limits of Detection of Six Approved RT?PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2)
32031590 ä. Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV)
32229107 2020. Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient
32031583 ä. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia
32156607 ä. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020
32343948 2020. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
32335089 ä. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories
32315614 2020. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients
32295319 2020. Innovative screening tests for COVID-19 in South Korea
32358960 ä. Evaluation of COVID-19 RT-qPCR test in multi-sample pools
32357209 ä. Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection
32357206 ä. Role of serology in the COVID-19 pandemic
32221523 ä. Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients
32221519 ä. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
32047895 ä. Consistent Detection of 2019 Novel Coronavirus in Saliva
32271374 ä. Effect of throat washings on detection of 2019 novel coronavirus
32337590 ä. Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
32120312 2020. Asymptomatic novel coronavirus pneumonia patient outside Wuhan: The value of CT images in the course of the disease
32302927 2020. Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review
32361535 ä. COVID-19 pneumonia patient without clear epidemiological history outside Wuhan: An analysis of the radiographic and clinical features
32361413 2020. Initial CT imaging characters of an imported family cluster of COVID-19
32358955 ä. Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection
32232429 ä. Computed Tomographic Imaging of 3 Patients With Coronavirus Disease 2019 Pneumonia With Negative Virus Real-time Reverse-Transcription Polymerase Chain Reaction Test
32227091 ä. Novel Coronavirus Pneumonia (COVID-19) Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section CT Features During Recovery
32198501 ä. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
32283324 ä. COVID-19 ? Considerations for the paediatric rheumatologist
32271865 ä. Generalizability of COVID-19 Clinical Prediction Models
32338708 ä. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
32271369 ä. Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score
32371555 2020. Utility of extracorporeal membrane oxygenation in COVID-19
32371563 2020. Asthma increases risk of severity of COVID-19
32360479 ä. 2019 novel coronavirus disease (COVID-19) in hemodialysis patients: a report of two cases
32360811 ä. Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts
32334081 ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
32249918 ä. Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study
32215613 ä. Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System?a Call for Epidemiologic Investigations
32182347 ä. Perinatal Transmissionof COVID-19 Associated SARS-CoV-2:Should We Worry?
32161941 ä. A case report of neonatal COVID-19 infection in China
32119083 ä. A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery
32271368 ä. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission
32270178 ä. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV
32353114 ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?
32339215 ä. Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for COVID-19
32337584 ä. First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit
32147731 ä. Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS
32227197 ä. A Community Transmitted Case of Severe Acute Respiratory Distress Syndrome due to SARS CoV2 in the United States
32211789 ä. The first locally acquired novel case of 2019-nCoV infection in a healthcare worker in the Paris area
32308494 2020. Epidemiologic and Clinical Characteristics of 26 Cases of COVID-19 Arising from Patient-to-Patient Transmission in Liaocheng, China
32361723 ä. Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China
32361738 ä. Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, China
32232322 ä. Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea
32211844 ä. Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan
32179890 ä. Risk Factors of Healthcare Workers with Corona Virus Disease 2019: A Retrospective Cohort Study in a Designated Hospital of Wuhan in China
32109279 ä. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study
32112072 ä. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features
32337591 ä. Early risk factors for the duration of SARS-CoV-2 viral positivity in COVID-19 patients
32176772 ä. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China
32371558 2020. Hydroxychloroquine use in the COVID-19 patient
32272008 2020. Early preemptive immunomodulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2
32337664 ä. Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
32359035 2020. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19
32272196 2020. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology
32247038 2020. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
32222466 2020. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
32360516 ä. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
32353634 2020. COVID-19: Immunology and treatment options
32335290 2020. A strategy targeting monocyte-macrophage differentiation to avoid pulmonary complications in SARS-Cov2 infection
32150618 ä. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
32211771 ä. Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
32211764 ä. Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019?
32266375 ä. Inquiring into Benefits of Independent Activation of Non-Classical Renin-Angiotensin System in the Clinical Prognosis and Reduction of COVID-19 mortality
32255489 ä. Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
32311512 ä. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19
32266381 ä. PCR Assays Turned Positive in 25 Discharged COVID-19 Patients
32166318 ä. Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak ?Lessons from Taiwan s SARS response
32371561 2020. Pulmonary function testing precautions in a time of COVID-19
32371560 2020. PAP therapy increases the risk of transmission of COVID-19
32252508 2020. Sharing Our Experience of Operating an Endoscopy Unit in the Midst of a COVID-19 Outbreak
32371164 ä. RECOMMENDATIONS FOR ESSENTIAL ESOPHAGEAL PHYSIOLOGICTESTING DURING THE COVID-19 PANDEMIC
32304737 ä. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic
32166310 ä. A Novel Approach for a Novel Pathogen: using a home assessment team to evaluate patients for 2019 novel coronavirus (SARS-CoV-2)
32246142 ä. Care for the psychological status of frontline medical staff fighting against COVID-19
32339218 ä. Working schedule, sleep quality and susceptibility to COVID-19 in healthcare workers
32371559 2020. Helping children cope with the COVID-19 pandemic
- Avoiding clinical medicine in other diseases
- Occupational medicine, workplace security and status hygienicus
- Economic aspects of the status hygienicus
- Educational aspects of the status hygienicus
- Host, vector, one health, atmospheric aspects
- Origin of Covid19
- Epidemiology
32227121 ä. The Late Arrival of COVID-19 in Africa - Mitigating Pan-Continental Spread
32201889 ä. COVID-19 Transmission Within a Family Cluster by Presymptomatic Carriers in China
32271372 ä. Asymptomatic and Presymptomatic Infectors: Hidden Sources of COVID-19 Disease
32255183 ä. Lockdown contained the spread of 2019 novel coronavirus disease in Huangshi city, China: Early epidemiological findings
32246149 ä. New measures for COVID-19 response: a lesson from the Wenzhou experience
32339245 ä. Contact tracing for COVID-19: An opportunity to reduce health disparities and End the HIV/AIDS Epidemic in the US
32339228 ä. Interactive web-based graphs of novel coronavirus COVID-19 cases and deaths per population by country
